Interstitial lung disease associated with docetaxel in a patient treated for breast cancer - a case report.

Monika Pankowska-Supryn, Monika Załęska, Barbara Roszkowska-Śliż, Kazimierz Roszkowski-Śliż
{"title":"Interstitial lung disease associated with docetaxel in a patient treated for breast cancer - a case report.","authors":"Monika Pankowska-Supryn,&nbsp;Monika Załęska,&nbsp;Barbara Roszkowska-Śliż,&nbsp;Kazimierz Roszkowski-Śliż","doi":"10.5603/PiAP.2015.0060","DOIUrl":null,"url":null,"abstract":"<p><p>Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibits normal interphase and mitotic cellular function, causing cell death. Docetaxel is indicated for the treatment of breast, lung and prostate cancers, head and neck cancer and gastric adenocarcinoma. Interstitial pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced interstitial lung disease (ILD) in a patient with breast cancer. </p>","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pneumonologia i alergologia polska","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/PiAP.2015.0060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibits normal interphase and mitotic cellular function, causing cell death. Docetaxel is indicated for the treatment of breast, lung and prostate cancers, head and neck cancer and gastric adenocarcinoma. Interstitial pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced interstitial lung disease (ILD) in a patient with breast cancer.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多西紫杉醇治疗乳腺癌患者间质性肺疾病1例报告
多西紫杉醇是一种半合成细胞抑制药物,属于类紫杉醇家族。多西紫杉醇抑制正常间期和有丝分裂细胞功能,导致细胞死亡。多西紫杉醇适用于乳腺癌、肺癌和前列腺癌、头颈癌和胃腺癌的治疗。间质性肺炎是多西他赛不常见的副作用。我们报告一例多西紫杉醇诱导间质性肺疾病(ILD)的患者乳腺癌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
20 weeks
期刊最新文献
[Systemic mastocytosis]. The clinical differences of asthma in patients with molds allergy. Tumor necrosis factor alpha as an asthma biomarker in early childhood. Prognostic value of TH1/TH2 cytokines in infants with wheezing in a three year follow-up study. Fungal infection of cystic fibrosis patients - single center experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1